4.6 Review

Control of Lyme borreliosis and other Ixodes ricinus-borne diseases

Journal

PARASITES & VECTORS
Volume 11, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s13071-018-2744-5

Keywords

Lyme borreliosis; Tick-borne encephalitis; Anaplasmosis; Ixodes ricinus; Transmission cycles; Vaccines; Prevention

Funding

  1. European Community's Seventh Framework Program [602272-2]
  2. Netherlands Organization for Scientific Research (ZON-MW) [50-52200-98-313]
  3. Federal Ministry of Education and Research (BMBF), 'Research Network Zoonotic Infectious Diseases' [01KI1720]

Ask authors/readers for more resources

Lyme borreliosis (LB) and other Ixodes ricinus-borne diseases (TBDs) are diseases that emerge from interactions of humans and domestic animals with infected ticks in nature. Nature, environmental and health policies at (inter) national and local levels affect the risk, disease burden and costs of TBDs. Knowledge on ticks, their pathogens and the diseases they cause have been increasing, and resulted in the discovery of a diversity of control options, which often are not highly effective on their own. Control strategies involving concerted actions from human and animal health sectors as well as from nature managers have not been formulated, let alone implemented. Control of TBDs asks for a health in all policies approach, both at the (inter) national level, but also at local levels. For example, wildlife protection and creating urban green spaces are important for animal and human well-being, but may increase the risk of TBDs. In contrast, culling or fencing out deer decreases the risk for TBDs under specific conditions, but may have adverse effects on biodiversity or may be societally unacceptable. Therefore, in the end, nature and health workers together must carry out tailor-made control options for the control of TBDs for humans and animals, with minimal effects on the environment. In that regard, multidisciplinary approaches in environmental, but also medical settings are needed. To facilitate this, communication and collaboration between experts from different fields, which may include patient representatives, should be promoted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available